BETAXOLOL HCL
BETA-BLOCKERS (SYSTEMIC) · HYPERTENSION
EPIC PHARMA LLC
Drug class
Beta-Blockers (Systemic)
Beta-blockers (systemic) are a therapeutic drug class comprising orally or parenterally administered beta-adrenergic receptor antagonists that competitively inhibit endogenous catecholamines throughout the body. Read more about Beta-Blockers (Systemic)
386 drugs in this class 143 manufacturers
Drugs in Beta-Blockers (Systemic)
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
Major Pharamceuticals
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
MYLAN INSTITUTI
METOPROLOL-HYDROCHLOROTHIAZIDE (metoprolol tartrate/hydrochlorothiazide)
DIURETICS · HYPERTENSION
SUN PHARMACEUTI
ESMOLOL HCL
BETA-BLOCKERS (SYSTEMIC) · PERIOPERATIVE HYPERTENSION ·+3
MYLAN INSTITUTI
METOPROLOL SUCCINATE
BETA-BLOCKERS (SYSTEMIC) · HYPERTENSION ·+2
DR.REDDY'S LAB
LABETALOL HCL
ALPHA-BLOCKERS · HYPERTENSION
PAR HEALTH USA,
PROPRANOLOL HCL ER (propranolol HCl)
BETA-BLOCKERS (SYSTEMIC) · MIGRAINE PREVENTION ·+3
BRECKENRIDGE
CARVEDILOL
ALPHA-BETA BLOCKERS · HYPERTENSION ·+2
BLUEPOINT LABOR
Filter & compare in the drug finder →
Opens the drug finder with Beta-Blockers (Systemic) preselected. Add indication or manufacturer filters there.
Beta-blockers (systemic) are a therapeutic drug class comprising orally or parenterally administered beta-adrenergic receptor antagonists that competitively inhibit endogenous catecholamines throughout the body.
By blocking cardiac beta-1 and peripheral beta-2 receptors, these medications exert negative inotropic and chronotropic effects, slowing the heart rate, decreasing myocardial contractility, and lowering systemic arterial blood pressure.
They are primarily indicated across cardiovascular medicine for the management of hypertension, angina pectoris, cardiac arrhythmias, myocardial infarction, and chronic heart failure with reduced ejection fraction.
Additionally, systemic beta-blockers play key therapeutic roles in non-cardiovascular conditions, including migraine prophylaxis, essential tremor, and the symptomatic management of thyrotoxicosis.
-
fda.gov
Beta-blockers (systemic) are a therapeutic drug class comprising orally or parenterally administered beta-adrenergic receptor antagonists that competitively inhibit endogenous catecholamines throughout the body By blocking cardiac beta-1 and peripheral beta-2 receptors, these medications exert negative inotropic and chronotropic effects, slowing the heart rate, decreasing myocardial contractility, and lowering systemic arterial blood pressure
-
nih.gov
Beta-blockers (systemic) are a therapeutic drug class comprising orally or parenterally administered beta-adrenergic receptor antagonists that competitively inhibit endogenous catecholamines throughout the body
-
nih.gov
By blocking cardiac beta-1 and peripheral beta-2 receptors, these medications exert negative inotropic and chronotropic effects, slowing the heart rate, decreasing myocardial contractility, and lowering systemic arterial blood pressure They are primarily indicated across cardiovascular medicine for the management of hypertension, angina pectoris, cardiac arrhythmias, myocardial infarction, and chronic heart failure with reduced ejection fraction Additionally, systemic beta-blockers play key ther...
-
mayoclinic.org
By blocking cardiac beta-1 and peripheral beta-2 receptors, these medications exert negative inotropic and chronotropic effects, slowing the heart rate, decreasing myocardial contractility, and lowering systemic arterial blood pressure
-
nih.gov
They are primarily indicated across cardiovascular medicine for the management of hypertension, angina pectoris, cardiac arrhythmias, myocardial infarction, and chronic heart failure with reduced ejection fraction
-
clevelandclinic.org
They are primarily indicated across cardiovascular medicine for the management of hypertension, angina pectoris, cardiac arrhythmias, myocardial infarction, and chronic heart failure with reduced ejection fraction Additionally, systemic beta-blockers play key therapeutic roles in non-cardiovascular conditions, including migraine prophylaxis, essential tremor, and the symptomatic management of thyrotoxicosis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.